SBI Pharma Fund - Direct (G)

Fund Class : Equity - Pharma
Fund House : SBI Mutual Fund
Aum(Rs Cr) : 65.14
NAV 17 Aug 2017 126.44 -0.92
(-0.72%)

NAV High-Low (in Rs)

ONE Mth
52-WEEk 847.18
1082.59

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 2.5 - - - 8.25
Sensex 1 -0.59 10.73 12.09 19.45
Nifty 1.3 0.1 11.51 13.42 24.93

Fund Features

Types of Scheme Growth
Options Equity
Assets Size (Rs in Cr) 65.14 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Tanmaya Desai

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 30 Jun 2017
Category Share (%)
Cash & Bank Balance & Bank Deposits 0.36
CBLO 4.60
Equity 96.35
› More
   As On 30 Jun 2017
Sector Name Amount
Healthcare 12.43
NA 4.96
Pharmaceuticals - Indian - Bulk Drugs 20.08
Pharmaceuticals - Indian - Bulk Drugs & Formln 54.43
Pharmaceuticals - Indian - Formulations 6.73
Pharmaceuticals - Multinational 2.68
› More
   As On 30 Jun 2017
Company Name
Strides Shasun 9.67
Aurobindo Pharma 8.09
Lupin 6.83
Cipla 6.56
Dr Reddy's Labs 5.78
Divi's Lab. 5.56
Thyrocare Tech. 4.30
Natco Pharma 4.30
› More

Fund DETAILS

Asset Management Co.

Registered Address

SBI Funds Management Ltd,

9th floorCrescenzoC-39&39
G BlockBandra-kurla complex
Bandra (east)Mumbai-400 051.

Phone: 022-61793000 | Fax: 022-2218 9663

Email: partnerforlife@sbimf.com

Website: www.sbimf.com